Sector dividends Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.80 USD | -0.89% |
|
-1.99% | -6.72% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -.--% | -.--% | 30.72x | 2.75x | 2.83x | 11.04x | 13.39x | 907.82Cr | |
| 1.1% | 1.26% | 29.89x | 3.83x | 5.3x | 16.42x | 23.05x | 4.36TCr | |
| -.--% | -.--% | -20.13x | 14.69x | 298.25x | -18.37x | -18.06x | 3.4TCr | |
| -.--% | -.--% | 21.71x | 4.11x | 2.51x | 10.86x | 16.55x | 2.98TCr | |
| -.--% | -.--% | 40.01x | 5.97x | 3.98x | 25.46x | 30.13x | 2.98TCr | |
| 0.4% | 0.4% | 29.57x | 2.2x | 7.61x | 19.57x | 23.36x | 2.54TCr | |
| -.--% | -.--% | 27.44x | 13.74x | 4.4x | 20.03x | 21x | 1.34TCr | |
| 1.21% | 1.41% | 22.01x | 2.31x | 1.91x | 8.41x | 13.32x | 1.29TCr | |
| -.--% | -.--% | -20.49x | 305.46x | 13.48x | -20.07x | -19.51x | 1.22TCr | |
| -.--% | -.--% | 23.51x | 1.16x | 1.7x | 10.26x | 11.75x | 1.13TCr | |
| -.--% | -.--% | -25.99x | 23.18x | 6.3x | 154.54x | -486.31x | 939.48Cr | |
| 0.57% | 0.57% | 48.17x | 4.08x | 7.22x | 20.47x | 22.51x | 879.45Cr | |
| -.--% | -.--% | -22.12x | 38.45x | 1677.13x | -23.93x | -24.52x | 786.87Cr | |
| -.--% | 0.51% | 17.65x | 2.01x | 3.79x | 10.11x | 12.94x | 765.37Cr | |
| -.--% | -.--% | -17.38x | 6.59x | 1521.8x | -14.36x | -13.64x | 737.51Cr | |
| -.--% | -.--% | -111.74x | 4.01x | 4.61x | 24.46x | 146.76x | 739.37Cr | |
| -.--% | -.--% | -24.3x | 6.26x | 67.49x | -15.14x | -14.61x | 704.04Cr | |
| -.--% | -.--% | 28.84x | - | 13.08x | 23.3x | 25.33x | 723.25Cr | |
| Average | 0.18% | 0.23% | 4.30x | 25.93x | 202.41x | 14.61x | -12.03x | 1.58TCr | |
| Weighted average by Cap. | 0.28% | 0.32% | 11.88x | 20.59x | 127.50x | 12.93x | -1.96x |
Select your edition
All financial news and data tailored to specific country editions
